Stocktoria
Aclaris Therapeutics, Inc. ACRS
Aclaris Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,387,081 | $12.6M | 1.95% |
| RENAISSANCE TECHNOLOGIES LLC | 817,531 | $4.3M | 0.67% |
| MILLENNIUM MANAGEMENT LLC | 523,895 | $2.8M | 0.43% |
| BlackRock Finance, Inc. | 2,032,155 | $2.2M | 1.66% |
| D. E. Shaw & Co., Inc. | 414,499 | $2.2M | 0.34% |
| TWO SIGMA INVESTMENTS, LP | 133,068 | $703,930 | 0.11% |
| AQR CAPITAL MANAGEMENT LLC | 60,259 | $318,771 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.